Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cunzhen Shi

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Hematological Oncology|July 7, 2022
Brentuxinmab vedotin, alone or combine with bendamustine in the treatment of natural killer T cell lymphomaPing Zhang, Cunzhen Shi, Yue Song, et al.
Journal of Cancer Research and Clinical Oncology|July 26, 2023
Development and validation of a prognostic model for esophageal cancer patients with liver metastasis: a cohort study based on surveillance, epidemiology, and end results databaseXiaolong Wu, Xudong Zhang, Jingjing Ge, et al.
Hematological Oncology|December 2, 2021
Synergistic anticancer effect of a combination of chidamide and etoposide against NK/T cell lymphomaWenting Song, Zhan Chen, Cunzhen Shi, et al.
BMC Medicine|July 13, 2023
PARP inhibitor exerts an anti-tumor effect via LMO2 and synergizes with cisplatin in natural killer/T cell lymphomaJiazhuo Wu, Cunzhen Shi, Hongwen Li, et al.
Hematological Oncology|April 19, 2022
The potential efficacy and mechanism of bendamustine in entra-nodal NK/T cell lymphomaYuyang Gao, Xiaoyan Feng, Wenting Song, et al.
Annals of Hematology|July 27, 2023
Enhanced efficacy of combined fluzoparib and chidamide targeting in natural killer/T-cell lymphomaChen Gong, Jiazhuo Wu, Wenting Song, et al.
Annals of Hematology|September 15, 2023
The experience of diagnosis and treatment for TAFRO syndromeXiaolong Wu, Xudong Zhang, Siyu Qian, et al.
Journal of Hematology & Oncology|March 21, 2018
The proto-oncogene Mer tyrosine kinase is a novel therapeutic target in mantle cell lymphomaCunzhen Shi, Xiangqun Li, Xiaogan Wang, et al.
Oncology Letters|November 30, 2016
Effects of microRNA-21 on the biological functions of T-cell acute lymphoblastic lymphoma/leukemiaCunzhen Shi, Xudong Zhang, Xin Li, et al.
Oncotarget|April 21, 2017
The Bruton's tyrosine kinase inhibitor ibrutinib exerts immunomodulatory effects through regulation of tumor-infiltrating macrophagesLingyan Ping, Ning Ding, Yunfei Shi, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Hematological Oncology|July 7, 2022
Brentuxinmab vedotin, alone or combine with bendamustine in the treatment of natural killer T cell lymphomaPing Zhang, Cunzhen Shi, Yue Song, et al.
Journal of Cancer Research and Clinical Oncology|July 26, 2023
Development and validation of a prognostic model for esophageal cancer patients with liver metastasis: a cohort study based on surveillance, epidemiology, and end results databaseXiaolong Wu, Xudong Zhang, Jingjing Ge, et al.
Hematological Oncology|December 2, 2021
Synergistic anticancer effect of a combination of chidamide and etoposide against NK/T cell lymphomaWenting Song, Zhan Chen, Cunzhen Shi, et al.
BMC Medicine|July 13, 2023
PARP inhibitor exerts an anti-tumor effect via LMO2 and synergizes with cisplatin in natural killer/T cell lymphomaJiazhuo Wu, Cunzhen Shi, Hongwen Li, et al.
Hematological Oncology|April 19, 2022
The potential efficacy and mechanism of bendamustine in entra-nodal NK/T cell lymphomaYuyang Gao, Xiaoyan Feng, Wenting Song, et al.
Annals of Hematology|July 27, 2023
Enhanced efficacy of combined fluzoparib and chidamide targeting in natural killer/T-cell lymphomaChen Gong, Jiazhuo Wu, Wenting Song, et al.
Annals of Hematology|September 15, 2023
The experience of diagnosis and treatment for TAFRO syndromeXiaolong Wu, Xudong Zhang, Siyu Qian, et al.
Journal of Hematology & Oncology|March 21, 2018
The proto-oncogene Mer tyrosine kinase is a novel therapeutic target in mantle cell lymphomaCunzhen Shi, Xiangqun Li, Xiaogan Wang, et al.
Oncology Letters|November 30, 2016
Effects of microRNA-21 on the biological functions of T-cell acute lymphoblastic lymphoma/leukemiaCunzhen Shi, Xudong Zhang, Xin Li, et al.
Oncotarget|April 21, 2017
The Bruton's tyrosine kinase inhibitor ibrutinib exerts immunomodulatory effects through regulation of tumor-infiltrating macrophagesLingyan Ping, Ning Ding, Yunfei Shi, et al.
Pageof 2